Internal Medicine, Infectious Disease · Orlando, FL
NPI
1265619266
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
2884 S Osceola Ave
Orlando, FL, 32806
Phone (407) 999-5225
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,522
69 services
Medicare patients, 2024
25
Average age 69
Drug cost, 2024
$3.7M
1,781 prescriptions
Company payments, 2025
$867
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Giron was code 99214 (office e&m - established), 38 times for 20 patients. In total Jose A Giron billed 69 services in 5 codes, and Medicare paid $7,522.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 38 | 20 | $86.03 | $3,269 |
| 99215 Office E&M - Established | Office | 25 | 15 | $136.30 | $3,407 |
By year: 2022 $14K for 110 services; 2023 $13K for 105 services; 2024 $7,522 for 69 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Giron prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 255 prescriptions and refills. In total Jose A Giron wrote 1,781 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 255 | 261 | 28 | $691K |
| Tivicay Dolutegravir Sodium | 192 | 192 | 19 | $376K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 176 | 176 | 20 | $620K |
| Descovy Emtricitabine/Tenofov Alafenam | 165 | 165 | 16 | $299K |
| Edurant Rilpivirine Hcl | 159 | 159 | 15 | $211K |
| Prezcobix Darunavir/Cobicistat | 118 | 118 | 13 | $257K |
| Juluca Dolutegravir/Rilpivirine | 78 | 78 | Under 11 | $254K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 55 | 55 | Under 11 | $182K |
| Pravastatin Sodium Generic | 36 | 44 | Under 11 | $175 |
| Vemlidy Tenofovir Alafenamide | 35 | 35 | Under 11 | $50K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 33 | 37 | Under 11 | $148K |
| Pifeltro Doravirine | 29 | 29 | Under 11 | $44K |
| Valacyclovir Valacyclovir Hcl | 24 | 24 | Under 11 | $645 |
| Doxycycline Hyclate Generic | 24 | 24 | 19 | $265 |
| Lamivudine Generic | 22 | 22 | Under 11 | $3,302 |
Brand drugs: 1,428 claims; generic drugs: 353 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Giron $867 ($867 in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $568.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.